Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
QJ

Qin Jiang — 17 Patents

ACAcucela: 4 patents #30 of 60Top 50%
ETEolas Therapeutics: 3 patents #3 of 10Top 30%
FCFred Hutchinson Cancer Research Center: 2 patents #78 of 333Top 25%
AGAgenebio: 2 patents #5 of 14Top 40%
SHSt. Jude Children'S Research Hospital: 2 patents #108 of 351Top 35%
Merck: 2 patents #3,930 of 9,382Top 45%
ICIcos: 1 patents #67 of 106Top 65%
University of Michigan: 1 patents #1,906 of 4,352Top 45%
Latham, NY: #20 of 218 inventorsTop 10%
New York: #8,526 of 115,490 inventorsTop 8%
Overall (All Time): #263,971 of 4,157,543Top 7%
17 Patents All Time
Qin Jiang has been granted 17 US patents while listed as an inventor at Acucela. The first was granted in 2005 and the most recent in May 2025. Qin Jiang ranks #263,971 of 4,157,543 US inventors in our database (top 6.3%). Patent records list Qin Jiang in Latham, NY, US.

Issued Patents All Time

Showing 1–17 of 17 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12291535 Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment Belew Mekonnen, John A. Butera, Jianxing Huang, Hemantbhai Patel, Robert Jason Herr +2 more 2025-05-06
11414425 Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment Belew Mekonnen, John A. Butera, Jianxing Huang, Hemantbhai Patel, Robert Jason Herr +2 more 2022-08-16
11220479 Glucosylceramide synthase inhibitors and therapeutic methods using the same Scott D. Larsen, James A. Shayman, Kim Hutchings, Neil Moss, Nicholas Mayhew +2 more 2022-01-11
10201545 Styrenyl derivative compounds for treating ophthalmic diseases and disorders Ian L. Scott, Vladimir A. Kuksa, Anna Gall, Mark W. Orme, Jennifer Lynn Gage +4 more 2019-02-12
9902738 Compounds and methods for preventing, treating and/or protecting against sensory hair cell death Julian Simon, Graham Johnson, Edwin Rubel, Sarwat Chowdhury, R. Jason Herr +3 more 2018-02-27
9896452 Substituted prolines/piperidines as orexin receptor antagonists Theodore Kamenecka, Yuanjun He, William Nguyen, Rong Jiang, Xinyi Song +1 more 2018-02-20
9499517 Substituted prolines / piperidines as orexin receptor antagonists Theodore Kamenecka, Yuanjun He, William Nguyen, Rong Jiang, Xinyi Song +1 more 2016-11-22
9469615 Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulators Christopher W. Boyce, Sylvia Degrado, Xiao-Tao Chen, Jun Qin, Robert Mazzola +20 more 2016-10-18 $133,900,000
9458508 Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitors Stephan W. Morris, Xiaoli Cui, Liquan Xue 2016-10-04
9440982 Substituted prolines/piperidines as orexin receptor antagonists Theodore Kamenecka, Yuanjun He, Rong Jiang, William Nguyen, Xinyi Song +1 more 2016-09-13
9421210 Styrenyl derivative compounds for treating ophthalmic diseases and disorders Ian L. Scott, Vladimir Aleksandrovich Kuska, Anna Gall, Mark W. Orme, Jennifer Lynn Gage +4 more 2016-08-23
9416141 Compounds and methods for preventing, treating and/or protecting against sensory hair cell death Julian Simon, Graham Johnson, Edwin Rubel, Sarwat Chowdhury, R. Jason Herr +3 more 2016-08-16
9314467 Styrenyl derivative compounds for treating ophthalmic diseases and disorders Ian L. Scott, Vladimir Aleksandrovich Kuska, Anna Gall, Mark W. Orme, Jennifer Lynn Gage +4 more 2016-04-19
8927559 Quinazolinone-type compounds as CRTH2 antagonists Robert G. Aslanian, Christopher W. Boyce, Robert Mazzola, Brian McKittrick, Kevin D. McCormick +20 more 2015-01-06 $93,479,000
8420863 Styrenyl derivative compounds for treating ophthalmic diseases and disorders Ian L. Scott, Vladimir A. Kuksa, Anna Gall, Mark W. Orme, Jennifer Lynn Gage +4 more 2013-04-16
8383793 Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitors Stephan W. Morris, Xiaoli Cui, Liquan Xue 2013-02-26
6924284 PARP inhibitors Graham Beaton, Wilna Moree, Jaimie Karyn Rueter, Russell Dahl, David L. McElligott +12 more 2005-08-02 $11,920,000